e-Drug3D

1452

FESOTERODINE


INN
FESOTERODINE

(has an active metabolite)

cas 286930-02-7
CLASS

ANTISPASMODICS
ANTIMUSCARINIC
MUSCARINIC ANTAGONIST
OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE
URINARY ANTISPASMODICS
GENITO
HYDROLYSIS BY NONSPECIFIC ESTERASES

ROUTE (list)

ORAL

ATC code

G04BD11

PK parameters

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET MUSCARINIC RECEPTOR ANTAGONIST

DrugCentral

Muscarinic acetylcholine receptor M2 UNIPROT P08172 CHRM2

Muscarinic acetylcholine receptor M3 UNIPROT P20309 CHRM3

Download SDF file Propanoic acid, 2-methyl-, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester

Formula:
C26H37NO3

Calculated chemical properties:

MW 411.57
NB_atoms 30
XLogP 5.38
PSA 47.623
NB_HD 1
NB_HA 4
fsp3 0.50
Lipinski(0=no;1=yes) 0

FDA
NDA 022030 (label) INN (FESOTERODINE FUMARATE) TOVIAZ (PFIZER) APPROVAL= AP YEAR= 2008
NDA 204844 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (SANDOZ INC) APPROVAL= TA YEAR= 2015
NDA 204893 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (LUPIN LTD) APPROVAL= TA YEAR= 2015 OBSOLETE
NDA 205032 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (SUN PHARM INDS INC) APPROVAL= TA YEAR= 2015
NDA 204827 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (ALKEM LABS LTD) APPROVAL= AP YEAR= 2015
NDA 205007 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2017
NDA 204946 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2017
NDA 204975 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (DR REDDYS) APPROVAL= AP YEAR= 2019
NDA 204504 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (ANI PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 204868 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 204973 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (ALEMBIC) APPROVAL= AP YEAR= 2023
NDA 204983 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (CHARTWELL RX) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 205002 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (AMNEAL PHARMS NY) APPROVAL= AP YEAR= 2023
NDA 205012 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 204792 (pdf not found) INN (FESOTERODINE FUMARATE) FESOTERODINE FUMARATE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1549

M FESOTERODINE


INN
FESOTERODINE

(is an active metabolite)

cas 207679-81-0
CLASS

ANTISPASMODICS
ANTIMUSCARINIC
MUSCARINIC ANTAGONIST
OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE
URINARY ANTISPASMODICS
GENITO
HYDROLYSIS BY NONSPECIFIC ESTERASES

ROUTE (list)

-

ATC code

G04BD11

PK parameters

F 52 PERCENT
Tmax 1.8 HOUR
Cmax 11.6 NANOMOLAR (8 MILLIGRAM)
VD 169 LITER
Cl 13.6 LITER / HOUR (EQN)
PPB 50 PERCENT
t1/2 8.59 HOUR

Target

TARGET MUSCARINIC RECEPTOR

DrugCentral

Muscarinic acetylcholine receptor M2 UNIPROT P08172 CHRM2

Muscarinic acetylcholine receptor M3 UNIPROT P20309 CHRM3

Download SDF file Benzenemethanol, 3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-

Formula:
C22H31NO2

Calculated chemical properties:

MW 341.48
NB_atoms 25
XLogP 4.53
PSA 46.686
NB_HD 2
NB_HA 3
fsp3 0.45
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL